Bristol Myers Squibb: Why I'm Pounding The Table On This Buying Opportunity (NYSE:BMY)

Bristol Myers Squibb offers a 5.6% dividend yield, strong cash flow, and AI-driven growth potential. See why I see this as a buying opportunity for BMY stock.